Skip to content
  • Saturday, 12 September 2026
  • 5:46 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule I
Laboratory Automation & Robotics

DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule I

Lana Keisha Sep 12, 2026 0

In a significant move to address the rising proliferation of potent, lab-engineered substances, the U.S. Drug Enforcement Administration (DEA) has…

Read More
The Integration of Artificial Intelligence in Diagnostic Medicine: A Paradigm Shift with Profound Implications for Radiology and Clinical LaboratoriesRecord-Breaking 220 PeV Cosmic Neutrino Detection Points to Blazars as Supreme Galactic AcceleratorsMIT Engineers Develop Dual Mode Propulsion System Integrating Chemical and Electric Thrusters for Small SatellitesScience News
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
TWiV 1287: Ancient herpesviruses and modern dementiaJohns Hopkins Researchers Discover How Fusion Genes Drive Rare Kidney Cancer Through Liquid DropletsRNA breakthrough provides hope for thousands of untreatable diseases, including cystic fibrosis, muscular dystrophy and some cancersMerck and Moderna’s cancer vaccine is customized for each patient’s tumor
YOU MAY HAVE MISSED
Microbiology & Immunology
TWiV 1287: Ancient herpesviruses and modern dementia
Lina Irawan Sep 12, 2026
Stem Cell & Regenerative Medicine
Johns Hopkins Researchers Discover How Fusion Genes Drive Rare Kidney Cancer Through Liquid Droplets
Dwi Wanna Sep 12, 2026
Biotech & Genetic Research
RNA breakthrough provides hope for thousands of untreatable diseases, including cystic fibrosis, muscular dystrophy and some cancers
Jia Lissa Sep 12, 2026
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Sep 12, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ